Experimental and Pharmacokinetic Studies in Intraperitoneal Chemotherapy: From Laboratory Bench to Bedside

作者: Eelco Bree , Dimitris D. Tsiftsis

DOI: 10.1007/978-3-540-30760-0_5

关键词:

摘要: Extrapolation of experimental results to clinical practice should be done very carefully, because the differences between conditions on laboratory bench and those in human body. In setting, circumstances are much more complicated drug activity is moderated by many physiological factors. On other hand, possibility creating standardized may great help for interpretation treatment efficacy since inter-individual encumber this process. Furthermore, studies provide indicative information that valuable it practically impossible study each parameter comparative studies. The relatively small number patients available intraperitoneal chemotherapy trials complicates evaluation optimal treatment.

参考文章(203)
P.J.M. van de Vaart, N. van der Vange, F.A.N Zoetmulder, A.R. van Goethem, O. van Tellingen, W.W. ten Bokkel Huinink, J.H. Beijnen, H. Bartelink, A.C. Begg, Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin–DNA adduct formation in patients and ovarian cancer cell lines European Journal of Cancer. ,vol. 34, pp. 148- 154 ,(1998) , 10.1016/S0959-8049(97)00370-5
G. Panteix, M. Guillaumont, L. Cherpin, J. Cuichard, F.N. Gilly, P.Y. Carry, A. Sayag, B. Salle, A. Brachet, J. Bienvenu, P. Baltassat, G. Braillon, Study of the Pharmacokinetics of Mitomycin C in Humans during Intraperitoneal Chemohyperthermia with Special Mention of the Concentration in Local Tissues Oncology. ,vol. 50, pp. 366- 370 ,(1993) , 10.1159/000227211
M. URANO, For the clinical application of thermochemotherapy given at mild temperatures. International Journal of Hyperthermia. ,vol. 15, pp. 79- 107 ,(1999) , 10.1080/026567399285765
D. Civalleri, M.O. Vannozzi, F. DeCian, G. Lunardi, M. Steinweg, I. Pastrone, M. Viale, M. Esposito, Intraperitoneal mitoxantrone: a feasibility and pharmacokinetic study. Ejso. ,vol. 28, pp. 172- 179 ,(2002) , 10.1053/EJSO.2001.1218
Faheez Mohamed, O.Anthony Stuart, Paul H Sugarbaker, Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions. Journal of Surgical Research. ,vol. 113, pp. 114- 120 ,(2003) , 10.1016/S0022-4804(03)00162-8
Pierre Jacquet, Andrew Averbach, O. Anthony Stuart, David Chang, Paul H. Sugarbaker, Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemotherapy and Pharmacology. ,vol. 41, pp. 147- 154 ,(1997) , 10.1007/S002800050721
Valerie K. Israel, Chun Jiang, Franco M. Muggia, Anil Tulpule, Susan Jeffers, Lawrence Leichman, C. Paul Morrow, Lynda Roman, C. Gail Leichman, Kenneth K. Chan, Intraperitoneal 5-fluoro-2′-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study Cancer Chemotherapy and Pharmacology. ,vol. 37, pp. 32- 38 ,(1995) , 10.1007/BF00685626
Jung Soo Lee, Toshio Takahashi, Akeo Hagiwara, Chihiro Yoneyama, Michitoshi Itoh, Tsunetoshi Sasabe, Shozo Muranishi, Shigeru Tashima, Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis Cancer Chemotherapy and Pharmacology. ,vol. 36, pp. 211- 216 ,(1995) , 10.1007/BF00685848
MinJian Xu, DavidS. Alberts, Potentiation of platinum analogue cytotoxicity by hyperthermia. Cancer Chemotherapy and Pharmacology. ,vol. 21, pp. 191- 196 ,(1988) , 10.1007/BF00262768
DJ Kerr, AM Young, JP Neoptolemos, M Sherman, P Van-Geene, A Stanley, D Ferry, JW Dobbie, B Vincke, J Gilbert, D el Eini, N Dombros, G Fountzilas, Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution British Journal of Cancer. ,vol. 74, pp. 2032- 2035 ,(1996) , 10.1038/BJC.1996.672